NADPH oxidase deficiency in X-linked chronic granulomatous disease
about
Chronic Granulomatous Disease; fundamental stages in our understanding of CGDPharmacology and Clinical Drug Candidates in Redox MedicineRedox modification of proteins as essential mediators of CNS autophagy and mitophagy.Pulmonary endothelial cell NOXActivation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms.Allosteric transformation of reduced nicotinamide adenine dinucleotide (phosphate) oxidase induced by phagocytosis in human polymorphonuclear leukocytesThe impact of intestinal inflammation on the nutritional environment of the gut microbiota.Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.Chronic granulomatous disease: a review of the infectious and inflammatory complications.Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear leukocytes from patients with chronic granNADPH-binding protein of the neutrophil superoxide-generating oxidase of guinea pigsChronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activationFurther characterization of NADPH oxidase activity of human polymorphonuclear leukocytes.Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay.Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.Oxygen dependence of human alveolar macrophage-mediated antibody-dependent cytotoxicity.Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model.Increased superoxide anion production by immunologically activated and chemically elicited macrophages.The dynamics of gut-associated microbial communities during inflammationSuppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.Proton secretion by stimulated neutrophils. Significance of hexose monophosphate shunt activity as source of electrons and protons for the respiratory burst.Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation.Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probesUse of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular eventsHydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases.H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders.Respiratory burst oxidase from human neutrophils: purification and some properties.Chronic granulomatous disease of childhood: clinical, pathological, biochemical, molecular, and genetic aspects of the disease.α-Defensins in human innate immunity.ROS and RNS signaling in skeletal muscle: critical signals and therapeutic targets.Manganese-dependent NADPH oxidation by granulocyte particles. The role of superoxide and the nonphysiological nature of the manganese requirement.The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst.NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.The clinical laboratory diagnosis of chronic granulomatous disease of childhood.The requirement for membrane sialic acid in the stimulation of superoxide production during phagocytosis by human polymorphonuclear leukocytes.The respiratory burst of phagocytes.Termination of the respiratory burst in human neutrophils.Subcellular localization of the superoxide-forming enzyme in human neutrophils.
P2860
Q21245653-C024E619-52F1-4A8E-AC00-E28382417F27Q26785525-D87BBA83-16F3-4C5E-BDA7-878C9B652282Q27687119-4CED77DE-0E0F-4B10-B0DB-69F85473F194Q33769358-8B488FF4-7A09-4445-9602-FEEFBCB232C9Q33821838-F6420E4C-F4B0-4513-8710-A9A14FBBD86FQ34445080-50D389B4-88E9-48FB-8B78-225B31CE8D90Q34451272-F1AE42B5-0821-4F2F-A8A9-6FA884DE4256Q34574739-593FA0B9-48A1-40EF-89CC-54BC02127288Q35084276-D964474F-B558-4424-B5E2-06FBBFED74C3Q35591061-B6BFA5F7-E161-4CCB-B681-7CFF0AF9698BQ35737890-C5473AD2-3068-40F0-8BC0-230C365706CBQ35810229-9CC0EEFC-2ABB-4811-B6C1-6D4F647B1533Q35904550-5E94F834-BDF0-40D8-8452-64E3C2F40129Q35905685-52B24785-E810-438B-B704-7296D87E3F4CQ36207505-185FE517-0F32-4EFC-B51D-82FFEFF55D00Q36335022-1AC0D50D-BB4A-42CD-B1FB-22E57F395213Q36340737-E3B512D3-9924-49F4-B658-B70C36C29F4EQ36341599-F4CFA5A3-9A04-42E0-A464-E02C881CF2D9Q36737912-2883F7FE-9E93-484F-9BFE-0971A7BD698CQ36982442-2DAF37DD-FA5C-403A-8FF3-357A926CDE65Q36992918-40EA5465-9324-4095-BAAE-BE394268A752Q36996467-9DB4A64A-25E0-49CC-B2A9-ED8BAE06869FQ37019090-08CB02A5-E38B-47FD-B19E-20D8FF170BB5Q37028052-51661A0F-4B18-49A4-980C-666403301931Q37037290-EC0FEAD9-C9AA-4589-B1FC-B76553895F3AQ37044859-3067CF16-13D3-426E-A71A-CD18E96BD353Q37048880-41631444-EC59-4680-9AE9-6388695D9CB7Q37174966-9C11D3D9-27F1-44D0-A89B-23DF988AAF53Q37687718-4D1FA75F-A76A-4786-9413-7F82E2211645Q37809364-377152EB-E16E-4ECC-A33C-3081D8798A8FQ37968296-633C178F-58AB-4A28-998E-4123162B39A2Q38217375-796A9C04-4730-4C9C-B9DB-025F2B6A921FQ39103737-340190D3-64D1-4FCA-B15D-C9B0D48C6AEAQ39113498-E2F79C8C-497A-49BB-9A9B-C6E249EEBEF1Q39496194-C62821BC-FF9E-4651-B611-6DFF83D64E4DQ39708366-68418D3B-4990-4FDD-B3A0-5833BA0F4692Q39990758-2954DCCE-3393-4D39-A5A5-FC6DB791250AQ40141105-3A269ED2-A7FB-447E-8819-2E94516C024AQ40152532-EC293F4F-6D68-41D8-B207-F8CDE1623799Q40204461-3B37C1D6-A04D-45CF-9740-51E37078BD0B
P2860
NADPH oxidase deficiency in X-linked chronic granulomatous disease
description
1975 nî lūn-bûn
@nan
1975 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@ast
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@en
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@nl
type
label
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@ast
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@en
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@nl
prefLabel
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@ast
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@en
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@nl
P2860
P356
P1476
NADPH oxidase deficiency in X-linked chronic granulomatous disease
@en
P2093
P2860
P304
P356
10.1172/JCI107980
P407
P577
1975-04-01T00:00:00Z